A 68-year-old male asked:
Would you agree with a recommendation to discontinue betaseron (interferon beta 1b) for a patient with secondary progressive ms, who no longer experiences relapses.
1 doctor answer • 1 doctor weighed in
Neurology 53 years experience
Yes: The american academy of neurology has issued an about lack of value of interferons and Copaxone in the treatment of secondary progressive ms, so not worthwhile to continue. However, there are newer oral meds, especially gilenya, (fingolimod) which may have promise with spms. Research studies may be available. Do monitor your vitamin d intake, and get about 5-10, 000 units daily.
Created for people with ongoing healthcare needs but benefits everyone.
4.9k viewsAnswered >2 years ago
Last updated Jun 24, 2014
Connect with a U.S. board-certified doctor by text or video anytime, anywhere.
24/7 visits - just $39!
50% off with $15/month membership
Content on HealthTap (including answers) should not be used for medical advice, diagnosis, or treatment, and interactions on HealthTap do not create a doctor-patient relationship. Never disregard or delay professional medical advice in person because of anything on HealthTap. Call your doctor or 911 if you think you may have a medical emergency.